DUSP5P1 and gastric cancer: Combination of Oxaliplatin with shDUSP5P1 synergistically suppressed cell migration of GC cells in vitro as well as lung and liver metastasis in vivo as compared with DUSP5P1 depletion or Oxaliplatin treatment alone, implying that DUSP5P1 serves as a potential target in platinum drug-resistant GC patients.